已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Osteoblastoma‐like osteosarcoma: high‐grade or low‐grade osteosarcoma?

成骨细胞瘤 骨肉瘤 医学 病理
作者
Marco Gambarotti,Angelo Paolo Dei Tos,D. Vanel,Piero Picci,Dino Gibertoni,Michael J. Klein,Alberto Righi
出处
期刊:Histopathology [Wiley]
卷期号:74 (3): 494-503 被引量:29
标识
DOI:10.1111/his.13746
摘要

Aims Osteoblastoma‐like osteosarcoma is a rare variant of osteosarcoma (1% of all osteosarcomas), histologically similar to osteoblastoma. In the current World Health Organisation ( WHO ) classification, osteoblastoma‐like osteosarcoma is classified within the group of conventional (high‐grade) osteosarcomas. However, several published cases have been actually regarded as low‐grade malignant tumours. As strict morphological criteria to distinguish between low‐ and high‐grade lesions are not available, we reviewed our series of osteoblastoma‐like osteosarcomas in the attempt to identify clinical and morphological features predictive of aggressiveness. Methods and results We retrieved 15 cases of osteoblastoma‐like osteosarcoma from the files of the Istituto Ortopedico Rizzoli. Patients received various treatments. Five patients developed metastasis and five patients developed local recurrences (all after incomplete surgery). Eleven patients were alive without disease, while four patients died of their disease. Statistical analysis revealed a statistically significant ( P = 0.048) lower disease‐free survival in patients with areas of conventional (high‐grade) osteosarcoma. Conclusions With the important limitation of a small cohort of patients, the presence of areas of conventional (high‐grade) osteosarcoma is the only parameter to predict the aggressiveness of osteoblastoma‐like osteosarcoma.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
chelly发布了新的文献求助10
刚刚
1秒前
时尚访卉发布了新的文献求助10
1秒前
2秒前
窦鞅发布了新的文献求助10
2秒前
4秒前
5秒前
米饭儿完成签到 ,获得积分10
5秒前
lf发布了新的文献求助10
6秒前
听雨发布了新的文献求助10
9秒前
11秒前
12秒前
12秒前
14秒前
15秒前
核桃完成签到,获得积分0
15秒前
星河发布了新的文献求助10
16秒前
沉默完成签到,获得积分10
17秒前
tracy发布了新的文献求助10
17秒前
18秒前
虚心的煎蛋完成签到 ,获得积分10
18秒前
佩吉发布了新的文献求助10
19秒前
GingerF应助科研通管家采纳,获得10
19秒前
shamy发布了新的文献求助10
20秒前
20秒前
Owen应助科研通管家采纳,获得10
20秒前
斯文败类应助科研通管家采纳,获得10
20秒前
英姑应助科研通管家采纳,获得10
20秒前
21秒前
21秒前
21秒前
赘婿应助Voloid采纳,获得10
21秒前
充电宝应助翁宇轩采纳,获得10
22秒前
22秒前
22秒前
核桃发布了新的文献求助30
22秒前
23秒前
Jepsen完成签到 ,获得积分10
27秒前
28秒前
chenchen完成签到,获得积分10
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6965440
求助须知:如何正确求助?哪些是违规求助? 8647068
关于积分的说明 18338548
捐赠科研通 6417285
什么是DOI,文献DOI怎么找? 3087479
关于科研通互助平台的介绍 2137774
邀请新用户注册赠送积分活动 2064045